Background: Chronic obstructive pulmonary disease (COPD) is a huge burden to the health care facility worldwide that is both substantial and increasing. Exacerbations of COPD have a negative impact on health status, rates of hospitalization and disease progression. However, there is still a lack of effective biomarkers...
Goutam Sen, Mushfiq Newaz Ahmed, Mir Mahmud et al.· Chest & Heart Journal· 0 citations
Background: Asthma exacerbation is a cause of major financial burden on any country. Many asthma patients remain symptomatic despite optimum treatment. Controlling the inflammatory response using a macrolide can be novel approach as one of the core underlying mechanisms in asthma is inflammation. This study evaluated t...
Mohammad Ashik Imran Khan, Mushfiq Newaz Ahmed, Manal Mizanur Rahman et al.· Chest & Heart Journal· 0 citations
Background: Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) lead to multiple hospital admissions, longer hospital stays as well as increased morbidity and mortality. Currently, no effective biomarker exists that can assess disease severity and activity in acute conditions. Serum uric acid is increased in...
Tanveer Kamal, Ashok Kumar Bhowmick, Dilruba Yeasmin et al.· Chest & Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.